CSIMarket
 


Vaxart Inc   (VXRT)
Other Ticker:  
 
 

VXRT's EPS from Cont. Operations Growth by Quarter and Year

Vaxart Inc 's EPS from Cont. Operations results by quarter and year




VXRT EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.11 -0.18 -0.17 -0.13
III Quarter September -0.11 -0.23 -0.14 -0.08
II Quarter June -0.16 -0.23 -0.13 -0.12
I Quarter March -0.19 -0.20 -0.14 -0.02
FY   -0.57 -0.84 -0.58 -0.35



VXRT EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
Vaxart Inc in the fourth quarter 2023 recorded EPS loss from Cont. Operations of $ -0.11 .

According to the results reported in the fourth quarter 2023, Vaxart Inc achieved the best EPS from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Vaxart Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2023.




VXRT EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vaxart Inc 's fourth quarter 2023 EPS from Cont. Operations $ -0.11 VXRT's Income Statement
Vaxart Inc 's fourth quarter 2022 EPS from Cont. Operations $ -0.18 Quarterly VXRT's Income Statement
New: More VXRT's historic EPS from Cont. Operations Growth >>


VXRT EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Vaxart Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VXRT's IV. Quarter Q/Q EPS from Cont. Operations Comment
Current results of -0.11 by Vaxart Inc look even worse considering the -0.11 in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Vaxart Inc achieved highest sequential EPS from Cont. Operations growth. While Vaxart Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VXRT's IV. Quarter Q/Q EPS from Cont. Operations Comment
Current accomplishment of -0.11 by Vaxart Inc appear even less good compare to the -0.11 EPS loss from Cont. Operations in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Vaxart Inc achieved highest sequential EPS from Cont. Operations growth. While Vaxart Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Vaxart Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.57 $ -0.64 $ -0.76 $ -0.83 $ -0.84
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Vaxart Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Vaxart Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
VXRT's EPS from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for VXRT's Competitors
EPS from Cont. Operations Growth for Vaxart Inc 's Suppliers
EPS from Cont. Operations Growth for VXRT's Customers

You may also want to know
VXRT's Annual Growth Rates VXRT's Profitability Ratios VXRT's Asset Turnover Ratio VXRT's Dividend Growth
VXRT's Roe VXRT's Valuation Ratios VXRT's Financial Strength Ratios VXRT's Dividend Payout Ratio
VXRT's Roa VXRT's Inventory Turnover Ratio VXRT's Growth Rates VXRT's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.95%$ -0.946 
Regeneron Pharmaceuticals Inc -2.77%$ -2.768 
Docgo Inc -3.90%$ -3.902 
Haemonetics Corporation-4.62%$ -4.615 
Edwards Lifesciences Corporation-5.96%$ -5.957 
Resmed Inc -7.19%$ -7.190 
Bristol myers Squibb Company-8.40%$ -8.397 
Gilead Sciences Inc -12.83%$ -12.832 
Utah Medical Products Inc-14.12%$ -14.124 
Masimo Corp-17.78%$ -17.782 
Merit Medical Systems Inc-18.28%$ -18.277 
Qiagen N v -19.35%$ -19.355 
Fresenius Medical Care Ag-26.09%$ -26.087 
Mettler toledo International Inc -28.51%$ -28.506 
Avantor Inc -30.61%$ -30.610 
Amedisys Inc -39.32%$ -39.315 
Avanos Medical Inc -39.47%$ -39.469 
Becton Dickinson And Company-43.27%$ -43.275 
Embecta Corp -43.55%$ -43.548 
Pro dex Inc -44.00%$ -44.000 
Harmony Biosciences Holdings inc -44.04%$ -44.044 
Bio techne Corp-46.88%$ -46.875 
Star Equity Holdings Inc -47.42%$ -47.416 
Amgen Inc -52.75%$ -52.746 
Biogen Inc -54.98%$ -54.977 
Taro Pharmaceutical Industries Ltd-56.13%$ -56.129 
Bio rad Laboratories Inc -56.74%$ -56.736 
Integra Lifesciences Holdings Corp-60.46%$ -60.461 
Henry Schein Inc-60.47%$ -60.467 
Teleflex Incorporated-60.61%$ -60.605 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com